Skip to contentK
Kewaunee Scientific Corp
K
KEQUKewaunee Scientific Corp Q3 2025 · 10-Q
Revenue$67.17M$67.17M+43.6% vs Q3 2024 Net Income$1.35M$1.35M−46.3% vs Q3 2024 EPS Diluted$0.45$0.45−47.1% vs Q3 2024 Gross Profit$18,379,000+52.8% Operating Income
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Kewaunee Scientific Corp · CIK 55529 · Engraved from SEC EDGAR
Operating Cash Flowderived-$2,266,000N/M Free Cash Flowderived-$2,955,000N/M Margins · derivedGross margin27.4%+1.6 pt vs Q3 2024
Operating margin3.3%−4.8 pt vs Q3 2024
Net margin2.0%−3.4 pt vs Q3 2024
ended Jan 31, 2025 · filed Mar 14, 2025 · 42 d after period end